nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrimeprazine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.504	1	CbGbCtD
Methotrimeprazine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0393	0.122	CbGeAlD
Methotrimeprazine—Priapism—Riluzole—amyotrophic lateral sclerosis	0.0321	0.209	CcSEcCtD
Methotrimeprazine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0184	0.12	CcSEcCtD
Methotrimeprazine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0155	0.101	CcSEcCtD
Methotrimeprazine—DRD1—nerve—amyotrophic lateral sclerosis	0.0135	0.0418	CbGeAlD
Methotrimeprazine—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0837	CcSEcCtD
Methotrimeprazine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0107	0.0698	CcSEcCtD
Methotrimeprazine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0671	CcSEcCtD
Methotrimeprazine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.0102	0.0318	CbGeAlD
Methotrimeprazine—HTR2A—pons—amyotrophic lateral sclerosis	0.0101	0.0314	CbGeAlD
Methotrimeprazine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00889	0.0579	CcSEcCtD
Methotrimeprazine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00886	0.0578	CcSEcCtD
Methotrimeprazine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.00864	0.0268	CbGeAlD
Methotrimeprazine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00846	0.0552	CcSEcCtD
Methotrimeprazine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0081	0.0528	CcSEcCtD
Methotrimeprazine—DRD2—nerve—amyotrophic lateral sclerosis	0.00796	0.0247	CbGeAlD
Methotrimeprazine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00792	0.0246	CbGeAlD
Methotrimeprazine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00741	0.023	CbGeAlD
Methotrimeprazine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00674	0.0209	CbGeAlD
Methotrimeprazine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00608	0.0189	CbGeAlD
Methotrimeprazine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00596	0.0185	CbGeAlD
Methotrimeprazine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00578	0.018	CbGeAlD
Methotrimeprazine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00541	0.0352	CcSEcCtD
Methotrimeprazine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00525	0.0163	CbGeAlD
Methotrimeprazine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0321	CcSEcCtD
Methotrimeprazine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0309	CcSEcCtD
Methotrimeprazine—DRD4—brain—amyotrophic lateral sclerosis	0.0046	0.0143	CbGeAlD
Methotrimeprazine—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00455	0.0141	CbGeAlD
Methotrimeprazine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00449	0.014	CbGeAlD
Methotrimeprazine—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.00438	0.0136	CbGeAlD
Methotrimeprazine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00423	0.0131	CbGeAlD
Methotrimeprazine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00408	0.0266	CcSEcCtD
Methotrimeprazine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00408	0.0127	CbGeAlD
Methotrimeprazine—DRD5—nervous system—amyotrophic lateral sclerosis	0.00397	0.0123	CbGeAlD
Methotrimeprazine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00393	0.0122	CbGeAlD
Methotrimeprazine—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00382	0.0119	CbGeAlD
Methotrimeprazine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00358	0.0111	CbGeAlD
Methotrimeprazine—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00356	0.011	CbGeAlD
Methotrimeprazine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00349	0.0108	CbGeAlD
Methotrimeprazine—CHRM4—brain—amyotrophic lateral sclerosis	0.00348	0.0108	CbGeAlD
Methotrimeprazine—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00343	0.0106	CbGeAlD
Methotrimeprazine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00342	0.0106	CbGeAlD
Methotrimeprazine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00325	0.0101	CbGeAlD
Methotrimeprazine—DRD3—brain—amyotrophic lateral sclerosis	0.00324	0.01	CbGeAlD
Methotrimeprazine—ADRA1D—nervous system—amyotrophic lateral sclerosis	0.00318	0.00987	CbGeAlD
Methotrimeprazine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00313	0.00973	CbGeAlD
Methotrimeprazine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00313	0.00972	CbGeAlD
Methotrimeprazine—ADRA1D—central nervous system—amyotrophic lateral sclerosis	0.00306	0.00951	CbGeAlD
Methotrimeprazine—DRD5—brain—amyotrophic lateral sclerosis	0.00303	0.00941	CbGeAlD
Methotrimeprazine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00303	0.00941	CbGeAlD
Methotrimeprazine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00292	0.00906	CbGeAlD
Methotrimeprazine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00279	0.00867	CbGeAlD
Methotrimeprazine—CHRM5—brain—amyotrophic lateral sclerosis	0.00272	0.00844	CbGeAlD
Methotrimeprazine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00249	0.00772	CbGeAlD
Methotrimeprazine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00246	0.00764	CbGeAlD
Methotrimeprazine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00244	0.00758	CbGeAlD
Methotrimeprazine—ADRA1D—brain—amyotrophic lateral sclerosis	0.00243	0.00755	CbGeAlD
Methotrimeprazine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00235	0.00731	CbGeAlD
Methotrimeprazine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00235	0.0073	CbGeAlD
Methotrimeprazine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.00232	0.00719	CbGeAlD
Methotrimeprazine—DRD1—brain—amyotrophic lateral sclerosis	0.00232	0.00719	CbGeAlD
Methotrimeprazine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00227	0.00704	CbGeAlD
Methotrimeprazine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00225	0.007	CbGeAlD
Methotrimeprazine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00222	0.0069	CbGeAlD
Methotrimeprazine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00214	0.00665	CbGeAlD
Methotrimeprazine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00207	0.00641	CbGeAlD
Methotrimeprazine—Trifluoperazine—SIGMAR1—amyotrophic lateral sclerosis	0.00206	0.651	CrCbGaD
Methotrimeprazine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00205	0.00638	CbGeAlD
Methotrimeprazine—CHRM3—nervous system—amyotrophic lateral sclerosis	0.00199	0.00618	CbGeAlD
Methotrimeprazine—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00192	0.00595	CbGeAlD
Methotrimeprazine—CHRM2—brain—amyotrophic lateral sclerosis	0.00187	0.0058	CbGeAlD
Methotrimeprazine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00185	0.00574	CbGeAlD
Methotrimeprazine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00183	0.00567	CbGeAlD
Methotrimeprazine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00181	0.00561	CbGeAlD
Methotrimeprazine—HTR2C—brain—amyotrophic lateral sclerosis	0.0018	0.00559	CbGeAlD
Methotrimeprazine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00179	0.00556	CbGeAlD
Methotrimeprazine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00176	0.00546	CbGeAlD
Methotrimeprazine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00174	0.0054	CbGeAlD
Methotrimeprazine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00172	0.00535	CbGeAlD
Methotrimeprazine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00172	0.00534	CbGeAlD
Methotrimeprazine—CHRM1—brain—amyotrophic lateral sclerosis	0.0017	0.00528	CbGeAlD
Methotrimeprazine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00169	0.00523	CbGeAlD
Methotrimeprazine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.00168	0.0052	CbGeAlD
Methotrimeprazine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00165	0.00512	CbGeAlD
Methotrimeprazine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00164	0.00509	CbGeAlD
Methotrimeprazine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00161	0.00501	CbGeAlD
Methotrimeprazine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00157	0.00488	CbGeAlD
Methotrimeprazine—CHRM3—brain—amyotrophic lateral sclerosis	0.00152	0.00472	CbGeAlD
Methotrimeprazine—HRH1—nervous system—amyotrophic lateral sclerosis	0.00141	0.00439	CbGeAlD
Methotrimeprazine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.0014	0.00435	CbGeAlD
Methotrimeprazine—ADRA1A—brain—amyotrophic lateral sclerosis	0.0014	0.00433	CbGeAlD
Methotrimeprazine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00139	0.00431	CbGeAlD
Methotrimeprazine—DRD2—brain—amyotrophic lateral sclerosis	0.00137	0.00425	CbGeAlD
Methotrimeprazine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00423	CbGeAlD
Methotrimeprazine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00136	0.00422	CbGeAlD
Methotrimeprazine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00134	0.00415	CbGeAlD
Methotrimeprazine—ADRA2C—brain—amyotrophic lateral sclerosis	0.00133	0.00413	CbGeAlD
Methotrimeprazine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.00131	0.00406	CbGeAlD
Methotrimeprazine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00131	0.00406	CbGeAlD
Methotrimeprazine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00128	0.00397	CbGeAlD
Methotrimeprazine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00118	0.00367	CbGeAlD
Methotrimeprazine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00114	0.00353	CbGeAlD
Methotrimeprazine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00111	0.00345	CbGeAlD
Methotrimeprazine—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.00111	0.349	CrCbGaD
Methotrimeprazine—HRH1—brain—amyotrophic lateral sclerosis	0.00108	0.00336	CbGeAlD
Methotrimeprazine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00108	0.00334	CbGeAlD
Methotrimeprazine—ADRA2A—brain—amyotrophic lateral sclerosis	0.00106	0.0033	CbGeAlD
Methotrimeprazine—CYP2E1—brain—amyotrophic lateral sclerosis	0.00104	0.00322	CbGeAlD
Methotrimeprazine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00104	0.00322	CbGeAlD
Methotrimeprazine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00101	0.00314	CbGeAlD
Methotrimeprazine—HTR2A—brain—amyotrophic lateral sclerosis	0.000903	0.0028	CbGeAlD
Methotrimeprazine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000822	0.00255	CbGeAlD
Methotrimeprazine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.54e-06	0.000479	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	8.49e-06	0.000477	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.48e-06	0.000476	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.42e-06	0.000473	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—VEGFA—amyotrophic lateral sclerosis	8.31e-06	0.000467	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.3e-06	0.000466	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	8.28e-06	0.000465	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.24e-06	0.000463	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	8.15e-06	0.000458	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	8.11e-06	0.000456	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.05e-06	0.000452	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.95e-06	0.000446	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.95e-06	0.000446	CbGpPWpGaD
Methotrimeprazine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.93e-06	0.000445	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.92e-06	0.000445	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.91e-06	0.000444	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.9e-06	0.000444	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.88e-06	0.000443	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.87e-06	0.000442	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.85e-06	0.000441	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	7.84e-06	0.00044	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.81e-06	0.000438	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.77e-06	0.000436	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	7.76e-06	0.000436	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.75e-06	0.000435	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.73e-06	0.000434	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.71e-06	0.000433	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.61e-06	0.000427	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	7.6e-06	0.000427	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.58e-06	0.000425	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.57e-06	0.000425	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.48e-06	0.00042	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.47e-06	0.00042	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.47e-06	0.00042	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	7.47e-06	0.00042	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.36e-06	0.000414	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.36e-06	0.000413	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.35e-06	0.000412	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.32e-06	0.000411	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.3e-06	0.00041	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.29e-06	0.000409	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	7.25e-06	0.000407	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.23e-06	0.000406	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.21e-06	0.000405	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	7.2e-06	0.000404	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.14e-06	0.000401	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.12e-06	0.0004	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.09e-06	0.000398	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.03e-06	0.000395	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.03e-06	0.000395	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.02e-06	0.000394	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.99e-06	0.000393	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.9e-06	0.000388	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.9e-06	0.000387	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.89e-06	0.000387	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.87e-06	0.000386	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.84e-06	0.000384	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.83e-06	0.000383	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.78e-06	0.000381	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.76e-06	0.00038	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.75e-06	0.000379	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.7e-06	0.000376	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.68e-06	0.000375	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.61e-06	0.000371	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.58e-06	0.000369	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.56e-06	0.000368	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.54e-06	0.000367	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.52e-06	0.000366	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.51e-06	0.000366	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.48e-06	0.000364	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.46e-06	0.000363	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.44e-06	0.000362	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	6.43e-06	0.000361	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.42e-06	0.000361	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.34e-06	0.000356	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	6.31e-06	0.000354	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.3e-06	0.000354	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.29e-06	0.000353	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	6.28e-06	0.000353	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	6.28e-06	0.000353	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.27e-06	0.000352	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.26e-06	0.000352	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.21e-06	0.000349	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.21e-06	0.000349	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	6.2e-06	0.000348	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.15e-06	0.000345	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	6.09e-06	0.000342	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.98e-06	0.000336	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.93e-06	0.000333	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	5.87e-06	0.00033	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	5.87e-06	0.000329	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.86e-06	0.000329	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.83e-06	0.000328	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	5.83e-06	0.000327	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.78e-06	0.000325	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.78e-06	0.000325	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.76e-06	0.000323	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.75e-06	0.000323	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.72e-06	0.000321	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.63e-06	0.000316	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.62e-06	0.000315	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.61e-06	0.000315	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.61e-06	0.000315	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.6e-06	0.000314	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.58e-06	0.000313	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.53e-06	0.00031	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.51e-06	0.000309	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.39e-06	0.000302	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.38e-06	0.000302	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.38e-06	0.000302	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.31e-06	0.000298	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.3e-06	0.000298	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.29e-06	0.000297	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.29e-06	0.000297	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.28e-06	0.000296	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.26e-06	0.000296	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.25e-06	0.000295	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.24e-06	0.000294	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.22e-06	0.000293	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.2e-06	0.000292	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.18e-06	0.000291	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	5.16e-06	0.00029	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	5.15e-06	0.000289	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.12e-06	0.000288	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.08e-06	0.000285	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	5.01e-06	0.000282	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.88e-06	0.000274	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.84e-06	0.000272	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.81e-06	0.00027	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.8e-06	0.000269	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.78e-06	0.000268	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.78e-06	0.000268	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	4.76e-06	0.000268	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.76e-06	0.000267	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.75e-06	0.000267	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	4.74e-06	0.000266	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.68e-06	0.000263	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.67e-06	0.000262	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.65e-06	0.000261	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.64e-06	0.00026	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.59e-06	0.000258	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.58e-06	0.000257	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.42e-06	0.000248	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.35e-06	0.000244	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	4.35e-06	0.000244	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.34e-06	0.000244	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.33e-06	0.000243	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.32e-06	0.000242	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.31e-06	0.000242	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.27e-06	0.00024	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.26e-06	0.000239	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.25e-06	0.000239	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.14e-06	0.000233	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.14e-06	0.000233	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.08e-06	0.000229	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.08e-06	0.000229	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	4.03e-06	0.000226	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.02e-06	0.000226	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	4e-06	0.000224	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.97e-06	0.000223	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.96e-06	0.000222	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.91e-06	0.00022	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.91e-06	0.00022	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.86e-06	0.000217	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.75e-06	0.000211	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.73e-06	0.000209	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.7e-06	0.000208	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.68e-06	0.000207	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.68e-06	0.000207	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.66e-06	0.000205	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.6e-06	0.000202	CbGpPWpGaD
Methotrimeprazine—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.6e-06	0.000202	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.59e-06	0.000202	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.58e-06	0.000201	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.57e-06	0.0002	CbGpPWpGaD
Methotrimeprazine—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.54e-06	0.000199	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.53e-06	0.000198	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.52e-06	0.000198	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.52e-06	0.000198	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.51e-06	0.000197	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.48e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.48e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.47e-06	0.000195	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.46e-06	0.000194	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.32e-06	0.000186	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.32e-06	0.000186	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.27e-06	0.000184	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.25e-06	0.000182	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.19e-06	0.000179	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.18e-06	0.000178	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.16e-06	0.000178	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.14e-06	0.000176	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.12e-06	0.000175	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.12e-06	0.000175	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.1e-06	0.000174	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	3.09e-06	0.000173	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.05e-06	0.000171	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.01e-06	0.000169	CbGpPWpGaD
Methotrimeprazine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.98e-06	0.000167	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.93e-06	0.000165	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.88e-06	0.000162	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.82e-06	0.000158	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.81e-06	0.000158	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.77e-06	0.000155	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.76e-06	0.000155	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.75e-06	0.000155	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.75e-06	0.000154	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.72e-06	0.000153	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.71e-06	0.000152	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.71e-06	0.000152	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.66e-06	0.000149	CbGpPWpGaD
Methotrimeprazine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.65e-06	0.000149	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.63e-06	0.000148	CbGpPWpGaD
Methotrimeprazine—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.62e-06	0.000147	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.62e-06	0.000147	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	2.61e-06	0.000147	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.61e-06	0.000147	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.6e-06	0.000146	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.59e-06	0.000146	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.59e-06	0.000145	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.57e-06	0.000144	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.56e-06	0.000144	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.52e-06	0.000141	CbGpPWpGaD
Methotrimeprazine—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.51e-06	0.000141	CbGpPWpGaD
Methotrimeprazine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.39e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.39e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.38e-06	0.000134	CbGpPWpGaD
Methotrimeprazine—ADRA1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.36e-06	0.000132	CbGpPWpGaD
Methotrimeprazine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.36e-06	0.000132	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.35e-06	0.000132	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.34e-06	0.000132	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.34e-06	0.000131	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.33e-06	0.000131	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.31e-06	0.00013	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.3e-06	0.000129	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.14e-06	0.00012	CbGpPWpGaD
Methotrimeprazine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.13e-06	0.00012	CbGpPWpGaD
Methotrimeprazine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.11e-06	0.000119	CbGpPWpGaD
Methotrimeprazine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.04e-06	0.000115	CbGpPWpGaD
Methotrimeprazine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.99e-06	0.000112	CbGpPWpGaD
Methotrimeprazine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.96e-06	0.00011	CbGpPWpGaD
Methotrimeprazine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.8e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.79e-06	0.000101	CbGpPWpGaD
Methotrimeprazine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.78e-06	9.97e-05	CbGpPWpGaD
Methotrimeprazine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.77e-06	9.95e-05	CbGpPWpGaD
Methotrimeprazine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.77e-06	9.92e-05	CbGpPWpGaD
Methotrimeprazine—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.76e-06	9.88e-05	CbGpPWpGaD
Methotrimeprazine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.74e-06	9.79e-05	CbGpPWpGaD
Methotrimeprazine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.74e-06	9.76e-05	CbGpPWpGaD
Methotrimeprazine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.62e-06	9.07e-05	CbGpPWpGaD
